Yiyang Zhao

Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China

Xiaohua Gu, Qiang Zhang, Yun-Bo Chu et al. · Lung Cancer · 2018 · 67 citations

Pemetrexed-based Chemotherapy, Oncology, Metronomic Therapy +6

Activation and negative feedback regulation of<i>SlHY5</i>transcription by the SlBBX20/21–SlHY5 transcription factor module in UV-B signaling

Guoqian Yang, Chunli Zhang, Huaxi Dong et al. · The Plant Cell · 2022 · 51 citations · Full text

Anti‑breast cancer activity of selected 1,3,5‑triazines via modulation of EGFR‑TK

Weixin Yan, Yiyang Zhao, Jianrong He · Molecular Medicine Reports · 2018 · 30 citations · Full text

Breast Oncology, Chemical 1,3,5‑Triazine, Pharmaceutical Chemistry +19

Endoplasmic Reticulum Stress Affects Cholesterol Homeostasis by Inhibiting LXRα Expression in Hepatocytes and Macrophages

Tian Wang, Yiyang Zhao, Zhongsheng You et al. · Nutrients · 2020 · 30 citations · Full text

Inflammatory Lung Disease, Lipid Peroxidation, Immunology +23

Fisetin inhibits the proliferation of gastric cancer cells and induces apoptosis through suppression of ERK 1/2 activation

Weixin Yan, Yiyang Zhao, Xiaoyu Ye · Oncology Letters · 2018 · 20 citations · Full text

Tumor Biology, Fisetin Treatment, Gastric Cancer Cells +13